The board of directors
MARKUS G. SCHRIBER A former managing director of DuPont de Nemours International in Geneva, Markus Schriber is the founder and president of Le Réseau, a nonprofit that promotes and facilitates the creation of high-tech startups. He is a director of ETeCH, Zurich, a member of the board of UNITEC (intellectual property transfer), a member of the academic council of Geneva University, and a former member of the board of Geneva Airport. Markus Schriber is president of Eclosion's board of directors.
| |
ROBIN E. OFFORD Prof. Robin Offord holds a PhD and a postgraduate degree from Cambridge University, which he gained at the molecular biology laboratory. He worked alongside three Nobel Prize winners, Frederick Sanger, César Milsteinand Dorothy Klug, and lectured at Oxford University for 14 years. He is director of the medical biochemistry department at Geneva University, and was president of its fundamental medicine section. For the past 25 years, Prof. Offord has been a scientific adviser to many large pharmaceutical and biotechnology companies. He has cofounded several startups: GeneProt, whose first president he was; the California-based Ciphergen and the Institut Suisse de Bioinformatique. He currently devotes most of his energy to the Mintaka Foundation, which he founded.
| |
WERNER SCHLEGEL Professor Schlegel gained a PhD at Eidgenössische Technische Hochschule Zürich, and continued his career at the National Institutes of Health in Bethesda, Maryland alongside Nobel Prize winner Martin Rodbell. He has conducted his own research in intracellular signaling at Geneva University since 1980. As director of the Fondation Pour Recherches Médicales since 1994, he has given the institution a major part in biotechnology transfer by assimilating several startups, including NovImmune SA. Schlegel holds numerous international posts, particularly in Japan, where he was a visiting professor at Kobe University in 1997 and Osaka University in 2004. He has cofounded a number of startups, including Europroteome AG, where he was president of the board of directors.
| |
EMANUELA DOSE-SARFATIS Emanuela Dose Sarfatis qualified as an attorney. She managed the legal department of a private bank in Lausanne and was a member of her local council before joining Geneva cantonal council in 1994. | |
ROBERT KUSTER Robert Kuster graduated in business studies from the University of Geneva, and lectured at the university’s faculty of economic and social sciences. He spent three years at Capelin Associates Ltd, was managing director of Gesplan SA and Gesplan Finanz Holding from 1973 to 1992, and cofounded the Swiss Equity Capital Association. Kuster was responsible for business promotion at the Department of the Economy, Employment and External Affairs until 2002, occupying numerous high-level posts. He is currently deputy secretary of the economic affairs directorate and head of economic development at the Department of the Economy and Health, vice president of the associations BioAlps and Swiss Biotech, and a member of the board delegated by the council of state to Eclosion SA, the founding council of the Fondation Genevoise pour l'Innovation Technologique, the supervisory council delegated by the Council of State to Société d'Economie Mixte d'Archamps et du Genevois, and the founding council of the Conseil de la Fondation Franco-Suisse pour la Recherche et la Technologie, which is currently being established. He is also president of the economy working group of the Comité Régional Franco-Genevois.
| |